Related Experiment Video
Updated: May 5, 2026

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models
Published on: May 3, 2017
Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in Psychosis.
Kate Merritt1, Philip McGuire, Alice Egerton
1Department of Psychosis Studies, Institute of Psychiatry, King's College London , London , UK.
Schizophrenia research suggests glutamate abnormalities may cause symptoms. Proton magnetic resonance spectroscopy (1H-MRS) studies link brain glutamate levels to symptom severity, but larger studies are needed.
Area of Science:
- Neuroscience
- Psychiatry
Background:
- The glutamate hypothesis of schizophrenia links NMDA receptor blockade to psychosis.
- Glutamate system dysfunction is implicated in schizophrenia's psychotic and cognitive symptoms.
Purpose of the Study:
- To review proton magnetic resonance spectroscopy (1H-MRS) studies on glutamate metabolites, symptoms, and cognition in schizophrenia.
- To explore the relationship between brain glutamate function and symptom severity.
Main Methods:
- Review of 1H-MRS studies investigating glutamatergic metabolites in clinical schizophrenia samples.
- Estimation of in vivo glutamatergic metabolite levels using 1H-MRS.
Main Results:
- Some studies suggest elevated anterior cingulate glutamate function correlates with more severe schizophrenia symptoms.
- In vivo magnetic resonance spectroscopy can assess brain glutamate in schizophrenia.
Conclusions:
- The glutamatergic system is a key target for novel schizophrenia treatments.
- Further research with larger, symptom-severity-selected patient samples is necessary to clarify glutamate's role.
Related Concept Videos
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Positive Symptoms Schizophrenia: Hallucinations and Delusions
Hallucinations
Hallucinations in...
Hepatic Encephalopathy
Psychosis and Antipsychotic Drugs: Overview

